UMIN-CTR Clinical Trial

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000012727
Receipt No. R000014868
Official scientific title of the study Prospective observational study evaluating clinical significance of serial quantification of PCT in respiratory diseases
Date of disclosure of the study information 2013/12/29
Last modified on 2016/04/04 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Prospective observational study evaluating clinical significance of serial quantification of PCT in respiratory diseases
Title of the study (Brief title) PCT in CAP
Region
Japan

Condition
Condition Respiratory diseases
Classification by specialty
Pneumology Infectious disease
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To clarify clinical significances of serial quantification of PCT in respiratory diseases.
Basic objectives2 Others
Basic objectives -Others To evaluate an usefulness of PCT as a prognositic biomarker of respiratoty diseases
Trial characteristics_1 Exploratory
Trial characteristics_2 Pragmatic
Developmental phase Not applicable

Assessment
Primary outcomes 30 day mortality
Key secondary outcomes Severity, initial treatment failure, causative pathogen of infectious diseases

In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field.

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required.

Eligibility
Age-lower limit
18 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Patients with respiratory diseases
Healthy individuals as control
Key exclusion criteria Patients without lung diseases
Target sample size 500

Research contact person
Name of lead principal investigator Masato Watanabe
Organization Fukujuji Hopital
Division name Respiratory Medicine Division
Address 3-1-24 Matsuyama, Kiyose, Tokyo, Japan
TEL 042-491-4111
Email masatowa1973@gmail.com

Public contact
Name of contact person Masato Watanabe
Organization Fukujuji Hopital
Division name Respiratory Medicine Division
Address 3-1-24 Matsuyama, Kiyose, Tokyo, Japan
TEL 042-491-4111
Homepage URL
Email masatowa1973@gmail.com

Sponsor
Institute Respiratory Medicine Division, Fukujuji Hospital
Institute
Department

Sponsor means an organization that is responsible for plan, deployment and
report of the research including funding management. It doesn't mean
funding agency". Therefore, all clinical trial should have the one.

Funding Source
Organization Wako Pure Chemical Industries, Ltd.
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization Japan

Other related organizations
Co-sponsor Kyorin University
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 複十字病院、杏林大学

Other administrative information
Date of disclosure of the study information
2013 Year 12 Month 29 Day

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2013 Year 12 Month 17 Day
Anticipated trial start date
2013 Year 12 Month 17 Day
Last follow-up date
2020 Year 01 Month 01 Day
Date of closure to data entry
2020 Year 01 Month 01 Day
Date trial data considered complete
2020 Year 01 Month 01 Day
Date analysis concluded
2020 Year 01 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information Randam sampling

Management information
Registered date
2013 Year 12 Month 29 Day
Last modified on
2016 Year 04 Month 04 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-bin/ctr_e/ctr_view.cgi?recptno=R000014868